The availability of effective, reliably accessible, and affordable treatments for snakebite
envenoming is a critical and long unmet medical need. Recently, small, synthetic toxin …

Snakebite is a major public health problem with an estimated global burden of 5 million
people per annum. Data on snakebite envenoming in children are very limited and is …

Introduction: Snakebite is an urgent, unmet global medical need causing significant
morbidity and mortality worldwide. Varespladib is a potent inhibitor of venom secretory …

Importance Bothropsvenom acts almost immediately at the bite site and causes tissue
damage. Objective To investigate the feasibility and explore the safety and efficacy of low …

Background Tropical infectious diseases and vaccine-preventable emergencies are the
mainstay of pre-travel consultations. However, non-communicable diseases, injuries and …

Snakebite envenoming is currently considered a neglected tropical disease, which affects
over 5 million people worldwide, and causes almost 150 000 deaths every year, as well as …

Snakebite is the only WHO-listed, not infectious neglected tropical disease (NTD), although
its eco-epidemiology is similar to that of zoonotic infections: envenoming occurs after a …

Introduction Snakebite envenoming (SBE) results in over 500 000 deaths or disabling
injuries annually. Varespladib methyl, an oral inhibitor of secretory phospholipase A2, is a …

Abstract Background There are 5000–10,000 snake envenomations annually in the United
States. Fortunately, few are fatal. In this study we review the epidemiology of fatal …

Introduction Snakebites are a leading cause of mortality and permanent disabilities
especially among children in tropical countries and rural areas such as Morocco. Thus, a …